Saturday, November 14, 2009, 3:00 PM - 4:30 PM
Room - Sleta / Jemez

Moderator

Howard Lotsof -- Dora Weiner Foundation, Staten Island, NY - Mr. Lotsof is the recipient of this year's Robert Randall Award for Achievement in the Field of Citizen Action

Presentations

Ibogaine in opioid detoxification: How do we know it works? How does it work? (The most often asked patient question)

Kenneth Alper, M.D. -- Associate Professor of Psychiatry and Neurology -- New York University School of Medicine. USA presentation slide show ppt Select slide show viewing mode.

Safety Issues and Cardiac Side-Effects in the Administration of Ibogaine HCl, as an Addiction Interrupter Drug. What we know, what we theorize and what we don't know.

Jeffrey D. Kamlet, MD, FASAM, DABAM -- Fellow, American Society of Addiction Medicine. USA presentation slide show ppt Select slide show viewing mode.

Ibogaine User Self-Help Groups: Cross Cultural Development

Dimitri Mobengo Mugianis -- Founding member, NYCAHN/VOCAL, NYC Drug Users Union. USA Ibogalife

An exploratory study of the short term effects of Ibogaine Treatment. Ibogaine Demographics.

Dr Anwar Jeewar, BDS, HRST, MSocSc -- Director - Minds Alive. South Africa Minds Alive     presentation - Ibogaine Demographics, PDF format

The Benefits & Risks of Treating with Ibogaine in a Clinical Setting: 3 Case Studies

Clare S. Wilkins -- Director, Pangea Biomedics.   Mexico   Pangea Biomedics

Bwiti and iboga, Working properly and safely with iboga or ibogaine and Ibogaine antidotes

Patrick Moughenda Mickala, Nganga, Massango and Mitsogho tribe, Gabon Iboga House

***

Description of the Ibogaine Session

The discovery of ibogaine's use as an anti-addictive from the West African plant, Tabernanthe iboga, has been principally championed by drug user advocates in the United States, Canada, Brazil, Mexico, New Zealand, Australia, Slovenia, Indonesia, Gabon and South Africa. Some scenes have grown while others have declined. After decades of drug availability suddenly supplies of ibogaine used in treatment was interrupted. Botanical sources had to be found and manufacturing technologies reevaluated by those skilled in the chemistry and manufacture. Amidst all of these changes, the sharing of knowledge, cross cultural understanding and the debt long owed to Africa was acknowledged precipitating the organization of a Federation of Worldwide Ibogaine Practitioners. This panel is that story.

Major clinics are thriving from Mexico to South Africa, clinical trials are pending in Israel and India, and new clinical research is being contemplated in New Zealand, S. Africa, and South America principally for indications to addiction though antibacterial and antiviral effects have been noted. Underground user self-help organizations in keeping with AA except they are not abstinence based are growing in cities where ibogaine is not generally available. What are ibogaine's potential benefits to society? And what are hindrances to manufacturing, accessing, and researching this unique substance? How does it work? What are its mechanisms of action in treating narcotic withdrawal? We herewith present the most exhaustive conference panel on ibogaine ever held. We gladly invite you to attend.

2009 International Drug Policy Reform conference web page
Return to Calendar of Ibogaine Conferences, Forums and Meetings
Return to What's New

---

Main | What's new | Search | Science | Opinion | Literature | Art | Links | Treatment | Bookshop | Feedback